Literature DB >> 19554667

In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy.

Kim A Radermacher1, Nelson Beghein, Sebastien Boutry, Sophie Laurent, Luce Vander Elst, Robert N Muller, Benedicte F Jordan, Bernard Gallez.   

Abstract

OBJECTIVES: Ultrasmall particles of iron oxide (USPIO) possess superparamagnetic properties and are used as negative contrast agent in magnetic resonance imaging (MRI) because of their strong T(2) and T(2)* effects. Besides this method, electron paramagnetic resonance (EPR) offers the unique capability to quantify these particles. The objective of this study was to evaluate a molecular marker for non invasive diagnosis and monitoring of inflammation. During inflammation cell adhesion molecules such as E-selectin are expressed on the endothelial cell surface. An E-selectin ligand was coupled to pegylated USPIO particles.
MATERIALS AND METHODS: Inflammation was induced by intramuscular injection of Freund's Complete Adjuvant in male NMRI mice. After intravenous injection of grafted or ungrafted USPIO particles, iron concentration in inflamed muscles was quantified ex vivo by X-band EPR. Particle accumulation was also assessed in vivo by L-Band EPR, as well as by T(2)-weighted MRI.
RESULTS: We determined the mean iron oxide concentration in inflamed muscles after injection of grafted or ungrafted UPSIO particles, which was 0.8% and 0.4% of the initially injected dose, respectively. By L-band EPR, we observed that the concentration of the grafted USPIO particles in inflamed muscles was twice higher than for the ungrafted particles. Using MRI experiments, a higher signal loss was clearly observed in the inflamed muscle when grafted particles were injected in comparison with the ungrafted particles.
CONCLUSION: Even taking into account a non specific accumulation of iron oxides, the targeting of USPIO particles with E-selectin ligands significantly improved the sensitivity of detection of inflamed tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554667     DOI: 10.1097/rli.0b013e3181a49639

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  16 in total

1.  Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.

Authors:  Adam J Cole; Allan E David; Jianxin Wang; Craig J Galbán; Hannah L Hill; Victor C Yang
Journal:  Biomaterials       Date:  2010-12-21       Impact factor: 12.479

Review 2.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.

Authors:  Morteza Mahmoudi; Mohammad A Sahraian; Mohammad A Shokrgozar; Sophie Laurent
Journal:  ACS Chem Neurosci       Date:  2011-02-04       Impact factor: 4.418

3.  Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI.

Authors:  Natalie L Adolphi; Kimberly S Butler; Debbie M Lovato; T E Tessier; Jason E Trujillo; Helen J Hathaway; Danielle L Fegan; Todd C Monson; Tyler E Stevens; Dale L Huber; Jaivijay Ramu; Michelle L Milne; Stephen A Altobelli; Howard C Bryant; Richard S Larson; Edward R Flynn
Journal:  Contrast Media Mol Imaging       Date:  2012 May-Jun       Impact factor: 3.161

Review 4.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

5.  CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging.

Authors:  Mohammad H El-Dakdouki; Kheireddine El-Boubbou; Medha Kamat; Ruiping Huang; George S Abela; Matti Kiupel; David C Zhu; Xuefei Huang
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

6.  Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging.

Authors:  Lucas W E Starmans; Dirk Burdinski; Nicole P M Haex; Rik P M Moonen; Gustav J Strijkers; Klaas Nicolay; Holger Grüll
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

7.  Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.

Authors:  Thomas R Cox; Janine T Erler
Journal:  Dis Model Mech       Date:  2011-02-14       Impact factor: 5.758

Review 8.  Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?

Authors:  Gerrit L ten Kate; Eric J G Sijbrands; Roelf Valkema; Folkert J ten Cate; Steven B Feinstein; Antonius F W van der Steen; Mat J A P Daemen; Arend F L Schinkel
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

9.  Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles.

Authors:  Qiu Guo; Yi Liu; Ke Xu; Ke Ren; WenGe Sun
Journal:  Int J Nanomedicine       Date:  2013-06-21

10.  Phage Display Screening for Tumor Necrosis Factor- α -Binding Peptides: Detection of Inflammation in a Mouse Model of Hepatitis.

Authors:  Coralie Sclavons; Carmen Burtea; Sébastien Boutry; Sophie Laurent; Luce Vander Elst; Robert N Muller
Journal:  Int J Pept       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.